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Abstract
Background:  When  performing  direct  and  indirect  skin  immunofluorescence  (DIF,  IIF)  in  bullous  pemphigoid  (BP)  utilizing  single 
fluorophores such as fluorescein isothiocyanate (FITC), the presence of ”background” fluorescence is commonly described. Aim of reporting 
this case: Our laboratory has noted that what is termed “background” could represent a complex immune response in BP, that may be present 
in addition to the classical deposits of immunoglobulins and/or complement at the dermal/epidermal basement membrane zone (BMZ). 
Therefore, we simultaneously used multiple colored fluorophores to further investigate this possibility. Case Report: A 68-year-old male was 
evaluated for the presence of rapidly appearing vesicles and bullae on the chest, with additional pruritus. Methods: Skin biopsies for 
hematoxylin and eosin (H&E) staining, as well as for DIF, IIF, salt split skin and immunohistochemistry (IHC) analyses were performed. 
Results: H&E staining demonstrated a subepidermal blistering disorder. Within the dermis, a mild, superficial and deep, perivascular 
infiltrate of lymphocytes, histiocytes and eosinophils was observed. A few infiltrate cells displayed positive DIF staining for CD5, CD8 and 
CD45 around dermal blood vessels, nerves and eccrine sweat glands. In contradistinction, CD4, CD56 and Granzyme B staining was 
predominantly negative in these areas. DIF, IIF and salt split skin studies revealed a strong presence of IgG, Complement/C3, IgM and 
fibrinogen in linear patterns at the BMZ. Around the upper dermal perivascular infiltrate, HAM56 and CD68 positive cells were also noted. 
Positive DIF staining for CD1a was found suprajacent to the blister in the epidermis. Utilizing identical antibodies, we repeated our staining 
with the IHC technique, to address the issue of autofluorescence in DIF staining. Our IHC findings correlated with DIF and IIF results. 
Conclusion: Using multiple DIF fluorophores in this case of BP, we observed autoantibodies to structures such dermal nerves, blood vessels 
and eccrine sweat glands, that were not appreciated using FITCI alone. We propose the use of this technique in autoimmune skin diseases. In 
addition, we observed a prominent T cytotoxic cell infiltrate, that warrants further characterization.
 
Streszczenie
Wstęp:  Podczas wykonywania bezpośredniej i pośredniej immunofluorescencji skóry (DIF, IIF) w pemfigoidzie (BP) wykorzystuje się 
pojedyncze fluorofory takie jak izotiocyjanian fluoresceiny (FITC), a obecność „tła” fluorescencji jest powszechnie opisane. Cel niniejszego 
raportu: Nasze laboratorium zanotowało, że to, co jest określane jako „tło” może stanowić kompleksową odpowiedź immunologiczną w BP, 
która może być obecna dodatkowo w postaci klasycznych depozytów immunoglobulin i/lub dopełniacza w skórze/naskórku strefie błony 
podstawnej (BMZ). Dlatego równoczesne stosowaliśmy wiele kolorów fluoroforów do dalszego zbadania tej możliwości. Opis przypadku: 
68-letni mężczyzna był oceniany pod kątem obecności szybko pojawiających się pęcherzyków i pęcherzy na piersi, z dodatkowym świądem. 
Metody: Przeprowadzono biopsje skóry z barwieniem hematoksyliną i eozyną (H&E), a także DIF, IIF, split skóry i immunohistochemiczną 
(IHC)  analizę.  Wyniki:  Barwienie  H&E  wykazało  subepidermalne  pęcherze.  W  obrębie  skóry  właściwej  obserwowanio  łagodne, 
powierzchowne i głębokie, okołonaczyniowe nacieki z limfocytów, histiocytów i eozynofilów. Kilka nacieków komórkowych wykazywało 
pozytywne zabarwienie DIF dla CD5, CD8 i CD45 wokół skórnych naczyń krwionośnych, nerwów i ekrynowych gruczołów potowych. W 
przeciwieństwie do teych badań, barwienia CD4, CD56 i Granzym B było przeważnie ujemne w tych obszarach. DIF, IIF i badanie splitu 
skórnego wykazały silną obecność IgG, komplement/C3, IgM i fibrynogenu w liniowych wzorach na BMZ. Pozytywne komórki zauważono 
również wokół górnych nacieków okołonaczyniowych w skórze, HAM56 i CD68. W bezpośrednio leżącym pęcherzu w naskórku stwierdzono 
pozytywne barwienie DIF dla CD1a. Wykorzystując identyfikację przeciwciał, powtarzaliśmy nasze barwienia techniką IHC, aby zająć się 
kwestią autofluorescencji w barwieniu DIF. Nasze badania IHC skorelowano z wynikami DIF i IIF. Wnioski: Wykorzystując wiele fluoroforów 
w DIF w tym przypadku BP, obserwowaliśmy autoprzeciwciała do takich struktur jak skórne nerwy, naczynia krwionośne i ekrynowe 
gruczoły potowych, które nie zostały określone za pomocą samego FITCI. Proponujemy wykorzystanie tej techniki w autoimmunologicznych 
chorobach skóry.  Ponadto zaobserwowaliśmy znaczącą T cytotoksyczność komórek naciekowych, co wymaga dalszej charakterystyki.
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  Current  theory  maintains  that  the  development 
of  skin  lesions  in  bullous  pemphigoid  (BP)  results  from 
destruction of components of the basement membrane zone 
(BMZ) within the dermal-epidermal junction, secondary to 
autoantibodies deposited at the BMZ [1,2]. Two glycoproteins 
of molecular weight 230 kD (BPAG1) and 180 kD (BPAG2) 
serve as primary autoantigens in BP [1-4]. In BP, histologic 
dermal  perivascular  inflammatory  infiltrates  containing 
lymphocytes and eosinophils are classically appreciated, and 
linear IgG and complement/C3 deposits observed along the 
BMZ of the dermal-epidermal junction [1-4].
Case report
  A  68-year-old  male  was  evaluated  for  a  two 
day duration of pruritic blisters on the chest. On physical 
examination, the chest displayed tense vesicles and bullae, 
with mild erythema at the lesional bases. A lesional skin biopsy 
was taken for hematoxylin and eosin (H&E) analysis. Biopsies 
for  direct  immunofluorescence  and  immunohistochemisty 
(DIF,  IHC)  studies  were  taken  from  the  edge  of  the 
blistering  area.  Serum  for  indirect  immunofluorescence 
(IIF)  and  salt  split  skin  studies  was  also  obtained  [1]. 
DIF, and IIF on salt split skin:  Our  DIF  and  IIF  were 
prepared  and  incubated  with  multiple  fluorochromes,  as 
previously described [1, 2, 4-13].
IHC: Performed as previously described [4-13].  For the 
IHC  we  utilized  antibodies  to  IgG,  IgA,  IgM,  IgD,  IgE, 
Complement/C1q,  Complement/C3c,  Complement/C3d, 
anti-fibrinogen, anti-albumin, anti-kappa light chains, anti-
lambda  light  chains,  anti-CD1a,  CD4,  CD5,  CD8,  CD45, 
CD56,  CD68,  S100,  mast  cell  tryptase  (MCT),  alpha  1 
anti-trypsin, metalloprotinase matrix 9  (MMP9),  linker of 
activated T cells (LAT), Zeta-chain-associated protein kinase 
70 (ZAP-70) and ribonucleoprotein protein (RNP).
Results
Microscopic description:
  Examination  of  the  H&E  tissue  sections 
demonstrated a subepidermal blistering disorder. Within 
the blister lumen, numerous eosinophils were present, with 
occasional  lymphocytes  also  seen.  Neutrophils  were  rare. 
Dermal  papillary  festoons  were  not  observed.  Within  the 
dermis, a mild, superficial, perivascular infiltrate was noted, 
with additional mild, deep infiltrates around nerves and eccrine 
sweat glands. The dermal infiltrate contained lymphocytes, 
histiocytes  and  eosinophils.  A  PAS  special  stain  showed 
reinforcement of the basement membrane zone (BMZ) of 
the  dermal-epidermal  junction,  and  no  fungal  organisms. 
DIF studies were performed utilizing simultaneous multiple 
antibody/multiple fluorochrome techniques, and revealed the 
following results: IgG (++, linear BMZ (salt split skin IIF 
demonstrated IgG on blister roof)1;  IgA (-); IgM (+, linear 
band under the BMZ); IgG/M/A (++, linear at BMZ and on 
dermal eccrine glands and deep nerves); IgD(+/-, epidermal 
keratinocyte  intracellular);  IgE  (-);  Complement/C1q  (-); 
Complement/C3 (+++, linear BMZ and on dermal eccrine 
glands); kappa light chains (++, linear BMZ and on dermal 
eccrine glands); lambda light chains (++, linear BMZ and 
on dermal eccrine glands); albumin (++, on dermal eccrine 
glands and deep nerves) and fibrinogen (++, linear BMZ, on 
dermal eccrine glands and deep nerves) (Fig. 1-3). The IHC 
studies showed a few infiltrate cells with positive staining for 
CD5, CD8 and CD45 around dermal blood vessels, nerves 
and eccrine sweat glands. In contradistinction, CD4, CD56 
and  Granzyme  B  staining  was  predominantly  negative  in 
these areas. DIF, IIF and salt split skin studies revealed a 
strong presence of IgG, Complement/C3, IgM and fibrinogen 
in  linear  patterns  at  the  BMZ. Around  the  upper  dermal 
perivascular  infiltrate,  positive  IHC  staining  for  HAM56 
and CD68 was noted. Positive staining for CD1a was found 
suprajacent to the blister in the epidermis. (Fig. 1-3).  Finally, 
p53 antibody was positive on a few cells in the epidermis 
above  the  blister.  Mast  cell  tryptase  (MCT)  was  strongly 
positive  around  most  of  the  upper  dermal  blood  vessels, 
where the primary dermal inflammatory process was seen.
By using multiple fluorophores, in this case of BP we observed 
autoantibodies to structures such dermal nerves, blood vessels 
and eccrine sweat glands, that were not appreciated utilizing 
FITCI alone. Thus, we propose the use of this technique in 
autoimmune skin disease workup. In addition, we observed 
a predominant T cytotoxic cell infiltrate that warrants further 
characterization.
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Figure 1. a. Positive BMZ staining utilizing 0.1 M sodium chloride salt split skin and indirect immunofluorescence (IIF). Note the 
positive staining on the upper/blister roof inner surface of the blister, using FITC conjugated anti-human complement/C3 (white 
arrow, yellow/green staining). The nuclei of the epidermal keratinocytes are counterstained with Dapi (light blue). b. Positive 
BMZ staining utilizing 0.1 M sodium chloride salt split skin and IIF. Note the positive staining on the lower/blister floor inner 
surface of the blister using FITC conjugated anti-human lambda light chain antibodies (white arrow, green staining). c. Positive 
PAS staining under the BMZ (blue arrow, red staining). d. Positive staining on a nerve with FITC conjugated anti-human IgG 
antibodies (red arrow, green staining). The neural cell nuclei are counterstained with Dapi (blue). e. Positive staining on a nerve 
utilizing FITC conjugated anti-human-IgG(red arrow, green staining). f. Positive staining on a nerve, using FITC conjugated anti-
human fibrinogen (red arrow, green staining). g. Positive eccrine sweat gland staining with FITC conjugated anti-human-IgG 
(white arrows, yellow/green staining). h. Positive eccrine sweat gland staining utilizing FITC conjugated anti-human complement/
C3 (white arrows, green staining). i. Simultaneous positive staining of a large, deep dermal nerve (red arrow) and a nearby eccrine 
sweat gland (white arrow) utilizing FITC conjugated anti-human-IgG (green staining).96   © Our Dermatol Online 2.2012
Figure 2. a. Positive linear staining on the BMZ utilizing FITC conjugated anti-human lambda light chain antibodies (white arrow, 
green staining). b. Positive linear staining on the BMZ utilizing Alexa 647 conjugated anti-human IgG (white arrow, red staining). 
c. Positive IHC staining for anti-human IgM in a pattern suggestive of dermal compartmentalization below under the BMZ (blue 
arrow, brown staining). d. Similar to c, but in this image, some upper dermal blood vessels are also positive for IgM(blue arrow, 
brown staining) e. Positive IHC staining with anti-human-IgE at the BMZ and on upper dermal blood vessels (blue arrows, brown 
staining). f. Positive IHC staining with mast cell Tryptase (MCT) around the upper dermal blood vessels (blue arrows, brown 
staining). g. Positive IHC staining with anti-human fibrinogen antibodies on upper dermal blood vessels (blue arrows, brown 
staining). h. Compartmentalization of IHC staining as a broad band under the BMZ with anti-human fibrinogen antibodies. Please 
note that the upper dermal blood vessels are also positive (brown staining). i. Positive IHC staining on a sub-epidermal cell 
infiltrate with CD5 antibodies (blue arrows, brown staining). © Our Dermatol Online 2.2012   97
Figure 3. a. Positive IHC staining for anti-human albumin antibody, deposited on upper dermal blood vessels and small capillaries 
(blue arrows, brown staining). b. Positive IHC staining for CD45, on cells below the BMZ and surrounding upper dermal blood 
vessels (blue arrows, brown staining).  c. Compartmentalization of IHC staining for Complement/C1q under the BMZ, and also 
involving upper dermal blood vessels and an eccrine gland ductus (blue arrows, brown staining). d. Positive IHC staining on 
Langerhans cells for CD1a, located within the epidermal stratum spinosum suprajacent to a bullous pemphigoid blister (blue 
arrow, brown staining). e. Positive IHC staining for CD3, on cells under the BMZ in the superficial dermis (blue arrow, brown 
staining). f. Eosinophils are noted on an H&E image, located within a perivascular upper dermal infiltrate (blue arrow). g. Positive 
IHC staining for Complement/C3 antibodies, present in a linear band along the BMZ and under the BMZ in a compartmentalized 
pattern in the upper dermis (blue arrows, brown staining). h. Note a similar IHC staining phenomenon as in g, but in this case 
using antibodies directed against human albumin (blue arrows, brown staining). i. Direct immunofluorescence (DIF) staining for 
FITC conjugated IgD; note the positive, punctate staining present within the epidermal stratum spinosum (red arrow, yellow/
green staining). Discussion
  Classic  research  regarding  immunoreactivity  in 
BP  has  focused  primarily  on  reactivity  against  the  BMZ. 
Multiple  animal  models  have  been  utilized  to  study  this 
disorder, including both active and passive forms [3,4,12]. 
Recently, some studies have focused not only on damage 
to  the  BMZ  of  the  skin,  but  also  on  damage  associated 
with dermal blood vessels and nerves. Recently, one study 
suggested  that  cardiovascular  events  and  thromboembolic 
diseases are important causes of death in patients with BP; 
the risk of stroke after a diagnosis of BP (relative to the 
general population) was investigated in Taiwan. The study 
sample included 390 patients with BP, versus 1950 matched 
subjects  in  a  comparison  group  [14].  Other  authors  have 
also  reported  statistically  significant  cardiovascular  and 
neurologic alterations between patients affected by BP and 
matched control groups [14-18].
As  we  have  previously  noted,  most  classic  skin 
immunofluorescence  studies  have  been  performed  with 
monofluorochome  techniques,  frequently  utilizing  FITC. 
Utilizing this technique, additional FITC staining in areas 
other than the dermal-epidermal junction was disregarded as 
insignificant, background autofluorescence. 
With  the  improvement  of  IHC  techniques  that  allow 
differentiation  between  autofluorescence  and  genuine, 
diagnostic fluorescence [19,20], these previous assumptions 
regarding BP autofluorescence are under reconsideration.
In regard to our observed reactivity against dermal eccrine 
sweat glands and blood vessels, these structures are rich in 
integrins and other possible antigenic candidates. Soluble 
E-selectin  (sE-selectin)  represents  an  isoform  of  cell 
membrane E-selectin, an adhesion molecule synthesized only 
by endothelial cells. Soluble E-selectin has been reported to 
be significantly increased in the sera of the patients with BP 
[21-23]. One of the endothelial sE-selectin inducers is tumor 
necrosis  factor-alpha  (TNF-alpha),  which  is  also  able  to 
enhance vascular endothelial growth factor (VEGF), a potent 
endothelium activator [21-23]. Thus, based on these reports 
and on our data, we suggest that further studies addressing 
BP autoreactivities in dermal sweat glands, nerves and blood 
vessels are warranted.
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